Research by Guégan et al. highlighted YAP and TAZ as essential mediators of YES1-induced transformation in hepatocytes, noting that increased YES1 activity is associated with poor prognosis in some HCC cases [66]. The gene discussed is YAP1; the disease is hepatocellular carcinoma.